Selegiline Hydrochloride Capsule
Product Images NDC 16571-659

4 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 16571-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

500ct

500ct
Label for Selegiline Hydrochloride Capsules, USP 5 mg by Rising Pharma Holdings, Inc. The oral capsules come in a 500-count package. The label includes dosage form, strength, manufacturer, and a barcode, along with storage and usage instructions.*
FDA Label Image

60ct

60ct
Label for Selegiline Hydrochloride Capsules, USP 5 mg by Rising Pharma Holdings, Inc. The label shows it is an oral capsule dosage form with 60 capsules in the package. The label includes the proprietary and generic name, strength, quantity, and a barcode. The label also indicates the product is prescription only.*
FDA Label Image

Chemical Structure (Chemstructure)

Chemical Structure (Chemstructure)
Chemical structure diagram of Selegiline Hydrochloride, showing its molecular arrangement with labeled functional groups and bonds.*
FDA Label Image

Adverse Reactions Table (Table Adverse Events V2)

Adverse Reactions Table (Table Adverse Events V2)
A data table showing the incidence of treatment-emergent adverse experiences in a placebo-controlled clinical trial for selegiline hydrochloride versus placebo. It lists adverse events with the number of patients reporting each event for selegiline hydrochloride (N=49) and placebo (N=50), including nausea, dizziness, abdominal pain, hallucinations, dry mouth, vivid dreams, and others, as well as events reported once in either group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.